|Videos|September 1, 2017

Evolving Paradigms

  • Non-Small Cell Lung Cancer
  • Volume 1
  • Issue 1

Dr. Bazhenova on Potential Impact of Immunotherapy in Non-Driver NSCLC

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses what potential impact immunotherapy agents could have on outcomes for patients with non-driver non–small cell lung cancer.


Latest CME